Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 113 institutions that hold shares in the stock, with a total of 24 Million shares, which have been reported (via 13F filing form) to have a value of $402 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rtw Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
3,257,347
shares
|
$54.7 Million
0.78% of portfolio
|
Q1 2024
Added 88.63%
|
|
Great Point Partners LLC
Greenwich, CT |
May 15, 2024 Q1 2024 |
2,620,545
shares
|
$44 Million
9.62% of portfolio
|
Q3 2023
New holding
|
|
Menora Mivtachim Holdings Ltd.
|
May 13, 2024 Q1 2024 |
2,303,031
shares
|
$38.6 Million
0.26% of portfolio
|
Q3 2023
Reduced 8.96%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
1,716,813
shares
|
$28.8 Million
0.0% of portfolio
|
Q1 2024
Reduced 0.14%
|
|
Cowen And Company, LLC
|
May 03, 2024 Q1 2024 |
1,626,589
shares
|
$27.3 Million
0.82% of portfolio
|
Q1 2024
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2024 Q1 2024 |
1,300,000
shares
|
$21.8 Million
0.04% of portfolio
|
Q1 2024
New holding
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,200,000
shares
|
$20.1 Million
0.02% of portfolio
|
Q4 2023
Added 13.21%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2024 Q1 2024 |
1,112,020
shares
|
$18.7 Million
0.04% of portfolio
|
Q1 2024
Added 782.56%
|
|
Jefferies Financial Group Inc.
New York, NY |
May 13, 2024 Q1 2024 |
840,000
shares
|
$14.1 Million
0.12% of portfolio
|
Q1 2024
New holding
|
|
Migdal Insurance & Financial Holdings Ltd.
|
May 01, 2024 Q1 2024 |
686,472
shares
|
$11.5 Million
0.16% of portfolio
|
Q1 2024
Added 5.89%
|
|
Harel Insurance Investments & Financial Services Ltd.
|
Apr 30, 2024 Q1 2024 |
673,487
shares
|
$11.3 Million
0.2% of portfolio
|
Q1 2024
Reduced 22.59%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
536,994
shares
|
$9.01 Million
0.0% of portfolio
|
Q1 2024
Added 9.41%
|
|
Silverarc Capital Management, LLC
|
May 14, 2024 Q1 2024 |
508,587
shares
|
$8.53 Million
2.56% of portfolio
|
Q1 2024
Reduced 3.2%
|
|
Wildcat Capital Management, LLC
|
May 14, 2024 Q1 2024 |
495,606
shares
|
$8.32 Million
2.57% of portfolio
|
Q2 2023
New holding
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
390,549
shares
|
$6.55 Million
0.0% of portfolio
|
Q1 2024
Reduced 14.19%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
323,952
shares
|
$5.44 Million
0.0% of portfolio
|
Q1 2024
Added 3.66%
|
|
Superstring Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
288,267
shares
|
$4.84 Million
2.86% of portfolio
|
Q1 2024
Added 12.86%
|
|
Opaleye Management Inc.
Boston, MA |
May 29, 2024 Q1 2024 |
270,000
shares
|
$4.53 Million
0.99% of portfolio
|
Q1 2024
Reduced 15.63%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
267,143
shares
|
$4.48 Million
0.0% of portfolio
|
Q1 2024
New holding
|
|
Laurion Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
250,600
shares
|
$4.21 Million
0.03% of portfolio
|
Q4 2023
Reduced 32.11%
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
232,500
shares
|
$3.9 Million
0.0% of portfolio
|
Q1 2024
Reduced 1.16%
|
|
Wells Fargo & Company
San Francisco, CA |
May 10, 2024 Q1 2024 |
212,280
shares
|
$3.56 Million
0.0% of portfolio
|
Q1 2024
Reduced 3.1%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
194,966
shares
|
$3.27 Million
0.0% of portfolio
|
Q1 2024
Added 14.28%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2024 Q1 2024 |
184,184
shares
|
$3.09 Million
0.38% of portfolio
|
Q1 2024
Added 4.95%
|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Apr 18, 2024 Q1 2024 |
146,329
shares
|
$2.46 Million
0.02% of portfolio
|
Q1 2024
Reduced 9.41%
|